会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • METHODS FOR THE IDENTIFICATION OF ZAP-70 INTERACTING MOLECULES AND FOR THE PURIFICATION OF ZAP-70
    • ZAP-70相互作用分子鉴定方法和ZAP-70纯化方法
    • WO2007137867A1
    • 2007-12-06
    • PCT/EP2007/004880
    • 2007-06-01
    • CELLZOME AGKRUSE, UlrichRAMSDEN, NigelDREWES, GerardEBERHARD, Dirk
    • KRUSE, UlrichRAMSDEN, NigelDREWES, GerardEBERHARD, Dirk
    • G01N33/574C12Q1/48C07K1/04G01N33/68
    • C12Q1/485C12N9/1205G01N33/57426G01N2333/91215G01N2500/02G01N2500/10
    • The invention provides in a first aspect a method for the identification of an ZAP-70 interacting compound, comprising the steps of a) providing a protein preparation containing phosphorylated ZAP-70, b) contacting the protein preparation with aminopyrido-pyrimidine ligand 24 immobilized on a solid support under conditions allowing the formation of an aminopyrido-pyrimidine ligand 24 - phosphorylated ZAP-70 complex, c) incubating the aminopyrido-pyrimidine ligand 24 — phosphorylated ZAP-70 complex with a given compound, and d) determining whether the compound is able to separate phosphorylated ZAP-70 from the immobilized aminopyrido-pyrimidine ligand 24. In a second aspect, the present invention relates to A method for the identification of an ZAP-70 interacting compound, comprising the steps of a) providing a protein preparation containing phosphorylated ZAP-70, b) contacting the protein preparation with ligand aminopyrido-pyrimidine ligand 24 immobilized on a solid support and with a given compound under conditions allowing the formation of an aminopyrido-pyrimidine ligand 24 - phosphorylated ZAP-70 complex, and c) detecting the aminopyrido-pyrimidine ligand 24 - phosphorylated ZAP-70 complex formed in step b). hi a third aspect, the invention provides a method for the identification of an ZAP-70 interacting compound, comprising the steps of: a) providing two aliquots of a protein preparation containing phosphorylated ZAP-70, b) contacting one aliquot with aminopyrido-pyrimidine ligand 24 immobilized on a solid support under conditions allowing the formation of an aminopyrido-pyrimidine ligand 24 - phosphorylated ZAP-70 complex, c) contacting the other aliquot with aminopyrido-pyrimidine ligand 24 immobilized on a solid support and with a given compound under conditions allowing the formation of an aminopyrido-pyrimidine ligand 24 - phosphorylated ZAP-70 complex, and d) determining the amount of aminopyrido- pyrimidine ligand 24 - phosphorylated ZAP-70 complex formed in steps b) and c). In a forth aspect, the invention relates to a method for the identification of an ZAP-70 interacting compound, comprising the steps of: a) providing two aliquots comprising each at least one cell containing phosphorylated ZAP-70, b) incubating one aliquot with a given compound, c) harvesting the cells of each aliquot, d) lysing the cells in order to obtain protein preparations, e) contacting the protein preparations with aminopyrido-pyrimidine ligand 24 immobilized on a solid support under conditions allowing the formation of an aminopyrido-pyrimidine ligand 24 - phosphorylated ZAP-70 complex, and f) determining the amount of aminopyrido-pyrimidine ligand 24 - phosphorylated ZAP-70 complex formed in each aliquot in step e).
    • 本发明在第一方面提供了一种用于鉴定ZAP-70相互作用化合物的方法,其包括以下步骤:a)提供含有磷酸化ZAP-70的蛋白质制剂,b)使蛋白质制剂与固定在其上的氨基吡啶并 - 嘧啶配体24接触 在允许形成氨基吡啶并嘧啶配体24-磷酸化ZAP-70复合物的条件下的固体支持物,c)将氨基吡啶并 - 嘧啶配体24-磷酸化ZAP-70复合物与给定化合物一起孵育,和d)测定化合物是否为 能够从固定化的氨基吡啶并嘧啶配体24分离磷酸化的ZAP-70。在第二方面,本发明涉及鉴定ZAP-70相互作用化合物的方法,包括以下步骤:a)提供含有 磷酸化ZAP-70,b)将蛋白质制备物与固定在固体支持物上的配体氨基吡啶并 - 嘧啶配体24接触, 给定化合物在允许形成氨基吡啶并嘧啶配体24-磷酸化ZAP-70复合物的条件下,和c)检测步骤b)中形成的氨基吡啶并 - 嘧啶配体24-磷酸化ZAP-70复合物。 第三方面,本发明提供了鉴定ZAP-70相互作用化合物的方法,包括以下步骤:a)提供含有磷酸化ZAP-70的蛋白质制剂的两个等分试样,b)使一个等分试样与氨基吡啶并 - 嘧啶 配体24在允许形成氨基吡啶并 - 嘧啶配体24-磷酸化ZAP-70复合物的条件下固定在固体支持物上,c)将其它等分试样与固定在固相载体上的氨基吡啶并 - 嘧啶配体24和在给定化合物条件下接触 允许形成氨基吡啶并 - 嘧啶配体24-磷酸化ZAP-70复合物,和d)测定步骤b)和c)中形成的氨基吡啶并 - 嘧啶配体24-磷酸化ZAP-70复合物的量。 在第四方面,本发明涉及一种鉴定ZAP-70相互作用化合物的方法,其包括以下步骤:a)提供两个等分试样,其包含每个至少一个含有磷酸化ZAP-70的细胞,b)将一个等分试样与 给定化合物,c)收获每个等分试样的细胞,d)裂解细胞以获得蛋白质制剂,e)使蛋白质制剂与固定在固体支持物上的氨基吡啶并 - 嘧啶配体24接触,条件允许形成氨基吡啶 - 嘧啶配体24-磷酸化ZAP-70复合物,和f)测定在步骤e)中在每个等分试样中形成的氨基吡啶并 - 嘧啶配体24-磷酸化ZAP-70复合物的量。